Press Releases

  • Highest bridge to human heart transplant rate of any heart device, 79%
  • Over 800 implants account for more than 180 patient years on the Total Artificial Heart


2010  :: 2009 ::  2008  ::  2007   ::  2006  ::  2005  ::  2004

Australian Transplant Games Champion Leads SynCardia Cycling Team
in El Tour de Tucson

Heart transplant recipient Bill Wohl spent 159 days on the CardioWest™ temporary Total Artificial Heart... read more

SynCardia Systems, Inc. Earns Frost & Sullivan Entrepreneurial Company
of the Year Award for CardioWest™ temporary Total Artificial Heart

SynCardia Systems, Inc., a privately held developer of biomechanical cardiac replacement and mechanical circulatory support devices, has been awarded the Frost & Sullivan 2005 Entrepreneurial Company of the Year Award... read more

SynCardia Recognizes One Year Milestone of FDA Approval
of CardioWest™ temporary Total Artificial Heart

SynCardia Systems, Inc., a privately held developer of biomechanical cardiac replacement and mechanical circulatory support devices, today recognizes the one year milestone of the FDA approval... read more

SynCardia Recognizes 20th Anniversary of First Successful
Bridge-to-Transplant Utilizing a Total Artificial Heart

SynCardia Systems, Inc., a privately held developer of biomechanical cardiac replacement and mechanical circulatory support devices, announced today the company is recognizing the milestone event... read more

SynCardia Announces Initial Implantation of the CardioWest™
temporary Total Artificial Heart at the Cleveland Clinic

SynCardia Systems, Inc., a privately held developer of biomechanical cardiac replacement and mechanical circulatory support devices, announced today implantation of its CardioWest™ temporary Total Artificial Heart... read more

SynCardia Announces Destination Therapy Implants
of Its Total Artificial Heart in Europe

SynCardia Systems, Inc., a privately held developer of biomechanical cardiac replacement and mechanical circulatory support devices, announced today use of its CardioWest™ temporary Total Artificial Heart... read more

American Heart Association Cites SynCardia’s CardioWest™ temporary Total Artificial Heart as Major Advance in Cardiovascular Medicine in 2004

SynCardia Systems, Inc., a privately held developer of biomechanical cardiac replacement and mechanical circulatory support devices... read more